ReviewCell2018

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Pascale André et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.